US Patent Litigations are now available. Check here

IP Verse

Graf Von Stosch patent opposition analysis

Latest oppositions filed by Graf Von Stosch

Explore patent oppositions filed by Graf Von Stosch against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jun 26, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2854831Manufacture Of DegarelixFERRINGApr 10, 2025
EP3529360Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionNOVARTISJan 17, 2025
EP3191120Use Of Il-17 Antagonists To Inhibit The Progression Of Structural Damage In Psoriatic Arthritis PatientsNOVARTISJan 10, 2025
EP3328416Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal DysplasiaBIOMARIN PHARMACEUTICALDec 13, 2024
EP3334747Charged Depth Filtration Of Antigen-Binding ProteinsAMGENJun 27, 2024
EP3373013Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility ComplexADAPTIMMUNEApr 18, 2024
EP3191517Cross Reactive Siglec AntibodiesINNATE PHARMAAug 3, 2021
EP2911684Il-15R Alpha Forms, Cells Expressing Il-15R Alpha Forms, And Therapeutic Uses Of Il-15R Alpha And Il-15/Il-15R Alpha ComplexesADMUNE THERAPEUTICSMar 19, 2020
EP2936158Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility ComplexADAPTIMMUNENov 12, 2019
EP2563906Improved Cell Cultivation ProcessNOVARTISAug 7, 2018

Top competitors of Graf Von Stosch